Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ali Kürşat Tuna"'
Autor:
Özcan Çeneli, Abdullah İçli, Şerif Ahmet Kandemir, Ali Kürşat Tuna, Mustafa Çağrı Ergün, Ahmet Lütfü Sertdemir, Atakan Tekinalp, Bahattin Engin Kaya, Sinan Demircioğlu
Publikováno v:
Genel Tıp Dergisi, Vol 34, Iss 1, Pp 51-56 (2024)
Background/Aims: Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative diseases. Along with the increase in myeloproliferative cell lines, they can cause various clinical outcomes such as arterial and venous thrombo
Externí odkaz:
https://doaj.org/article/7b6ea65e1ef54cc69f73d268ba5eb389
Publikováno v:
Genel Tıp Dergisi, Vol 33, Iss 3, Pp 309-315 (2023)
Background/Aims: An impaired immune response affects Coronavirus 2019 (COVID-19) disease progression. Immunities of both hemodialysis (HD) and Kidney Transplant (KTx) patients have already been suppressed. This study evaluated the prognostic laborato
Externí odkaz:
https://doaj.org/article/3b8c72c5f64c4a65b27e1d2dfe97166c
Autor:
Ali Kürşat TUNA, Atakan TEKİNALP, İbrahim KILINÇ, Sinan DEMİRCİOĞLU, Bahattin Engin KAYA, Özcan ÇENELİ, Fahriye KILINÇ
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 11, Iss 2, Pp 158-162 (2023)
Aim:In this study, it was aimed to compare serum periostin levels of patients with and without bone marrow fibrosis among newly diagnosed multiple miyeloma (MM) patients.Materials and Methods:Thirty patients who were diagnosed with fibrosis in bone m
Externí odkaz:
https://doaj.org/article/ae3c51c7bae8446d82dbf837d31c3fb8
Autor:
Atakan Tekinalp, Taha Ulutan Kars, Ali Kürşat Tuna, İbrahim Kılınç, Sinan Demircioğlu, Özcan Çeneli
Publikováno v:
Turkish Journal of Biochemistry. 47:770-774
Objectives We measured the serum periostin levels in patients with DLBCL and determined whether the levels reflected the clinical findings. Methods This was a case-control study. DLBCL patients diagnosed between March 2021 and October 2021 (n=36) and
Publikováno v:
Genel Tıp Dergisi.
Background/Aims: An impaired immune response affects Coronavirus 2019 (COVID-19) disease progression. Immunities of both hemodialysis (HD) and Kidney Transplant (KTx) patients have already been suppressed. This study evaluated the prognostic laborato
Autor:
Atakan Tekinalp, Hilal Akay Çizmecioğlu, Mevlüt Hakan Göktepe, Sinan Demircioğlu, Ali Kürşat Tuna, Melek Karakurt Eryılmaz
Publikováno v:
Acta Oncologica Turcica. 55:261-269